UCSF 19th Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2022
UCSF 19th Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2022
Couldn't load pickup availability
UCSF 19th Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2022
UCSF 19th Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2022
Include: 9 videos + 2 pdfs, size: 5.82 GB
Now in its 19th year, and presented by the department of epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. Specific topics will include the cell biology of osteoporosis, bone biomechanics, endocrine and nutrition aspects of osteoporosis, and advances in skeletal imaging. The course will also critically review current treatment options and preview new treatments. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis.
TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for physicians and other clinicians working with osteoporosis patients. It will also benefit researchers, technologists and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. This year the conference will focus on the latest clinical updates and controversies about diagnosis and pharmacologic therapies. No prior clinical or scientific training in osteoporosis is required.
Educational Objectives
An attendee completing this course will be able to:
- Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies, separately or in combination;
- Assess the benefits and risks of long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
- Perform a diagnostic evaluation of skeletal fragility when a congenital or acquired disorder other than osteoporosis is suspected;
- Describe the approach to osteoporosis in the geriatric population;
- Understand best practices and interpretation of dual-energy X-ray absorptiometry (DXA) scans.
Course Outline
| Thursday, August 4, 2022 | ||
| ANTIRESORPTIVE TREATMENT | ||
| 8:00 AM | Zoom Registration and login, housekeeping, overview | |
| 8:10 | Bisphosphonate Efficacy, Duration, and Drug Holidays: Maximize Benefits and Minimize Risk | Dennis M. Black, PhD |
| 8:45 | Q&A | |
| 8:55 | Long-Term Treatment With and Following Denosumab | Richard Eastell, MD, FRCP |
| 9:25 | Q&A | |
| 9:35 | Break | |
| ANABOLIC TREATMENT | ||
| 9:50 | Accurate Diagnosis of Vertebral Fracture | Richard Eastell, MD, FRCP |
| 10:10 | Q&A | |
| 10:20 | Anabolic Agents: Efficacy and Safety | Clifford J. Rosen, MD |
| 10:55 | Incorporating Anabolic Treatments into Osteoporosis Regimens | Anne L. Schafer, MD |
| 11:25 | Q&A | |
| 11:35 | The Future of Osteoporosis Trials: FNIH-FDA Project | Dennis M. Black, PhD |
| 11:55 | Q&A | |
| 12:00 PM | Lunch Break | |
| SPECIAL TOPICS IN OSTEOPOROSIS | ||
| 1:00 PM | When is Skeletal Fragility Not Osteoporosis? | |
| Part 1: Acquired Causes of Skeletal Fragility | Deborah Sellmeyer, MD | |
| 1:25 | Part 2: Genetic Causes of Skeletal Fragility | Edward Hsiao, MD, PhD |
| 1:45 | Q&A | |
| 1:55 | Osteoporosis in the Geriatric Population | Deborah Kado, MD |
| 2:20 | Q&A | |
| 2:30 | Break | |
| 2:40 | DXA Interpretation and Pitfalls | Deborah Sellmeyer, MD |
| 3:10 | Q&A | |
| 3:20 | Clinical Roundtable: Q&A with a Panel of Physicians | Deborah E. Sellmeyer, MD Anne L. Schafer, MD Clifford J. Rosen, MD Steven T. Harris, MD, FACP, FASBMR |
| 3:50 | Adjourn | |
| RECORDED CONTENT | ||
| 33:40:00 | Basics of Bone Biology | Daniel Bikle, MD, PhD |
| 33:30:00 | Epidemiology and Consequences of Fractures | Ann V. Schwartz, PhD |
| 40:44:00 | Osteoporosis Screening and Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis | Steven T. Harris, MD, FACP, FASBMR |
| 25:39:00 | Calcium Intake | Anne L. Schafer, MD |
| 41:47:00 | Vitamin D | Clifford Rosen, MD |
| 23:11 | Physical Activity for Skeletal Health | Wendy L. Katzman, PT, DPTSc |
| 45:00:00 | Monitoring: Before, During and After Treatment | Doug C. Bauer, MD |
| 35:57:00 | Glucocorticoid-Induced Osteoporosis | Jonathan Graf, MD |
Topics:
- 01 Basics of Bone Biology – Daniel Bikle, MD, PhD.mov
- 02 Epidemiology and Consequences of Fractures – Ann V. Schwartz, PhD.mov
- 03 Osteoporosis Screening and Diagnosis- BMD, FRAX and Assessment of Secondary Osteoporosis – Steven T. Harris, MD, FACP.mov
- 04 Calcium Intake – Anne L. Schafer, MD.mov
- 05 Vitamin D – Clifford Rosen, MD.mov
- 06 Physical Activity for Skeletal Health – Wendy L. Katzman, PT, DPTSc.mov
- 07 Monitoring Before, During and After Treatment.mp4
- 08 Glucocorticoid-Induced Osteoporosis – Jonathan Graf, MD.mov
- August 4.ts
- MEP23001_RecordedSyllabus.pdf
- MEP23001_Syllabus.pdf
